Frequency of Acute and Chronic Liver Diseases Diagnosed on Computed Tomography

Acute and Chronic Liver Diseases on CT

Authors

  • Mahnoor Akram University Institute of Radiological Sciences and Medical Imaging, The University of Lahore, Gujrat Campus
  • Akash John University Institute of Radiological Sciences and Medical Imaging, The University of Lahore, Gujrat Campus
  • Amina Sharif Bhatti University Institute of Radiological Sciences and Medical Imaging, The University of Lahore, Gujrat Campus
  • . Esha University Institute of Radiological Sciences and Medical Imaging, The University of Lahore, Gujrat Campus
  • Abid Ali Allied Health Sciences, University Institute of Radiological Sciences and Medical Imaging, The University of Lahore, Gujrat Campus

DOI:

https://doi.org/10.54393/pbmj.v5i4.375

Keywords:

Liver, Computed Tomography, Cirrhosis, Hepatic diseases

Abstract

Liver pathologies are affecting millions of people worldwide due to increasing risk factors and an unhealthy environment. Early diagnosis is essential to aid the treatment process and declined the mortality rate. Objective: To evaluate the frequency of acute and chronic hepatic diseases using multidetector Computed Tomography. Methods: The study was conducted in a private healthcare institute, with a sample size of 49 patients including 25 females and 24 males. Data were calculated by taking the mean via a convenient sampling approach, after informed consent. All the patients diagnosed with various liver diseases during the CT scan investigation presented at the study area within the period of study were included. Data was entered and analyzed by using SPSS version 20. Results: According to the current study, the patients from 46 -65 years 28(57.1%) had the highest frequency, and the females 25(51.0%) were more likely to develop liver diseases than males 24(49.0%). The frequency of chronic liver diseases includes cirrhotic patients 17(34.7%), liver masses 30(61.2%), calcified granuloma 2(4.1%), fatty infiltration 4(8.2%), and cysts 3(6.1%). Most of the patients having cirrhosis were also associated with liver masses 20(40.8%).

References

Cullen JM and Stalker MJ. Liver and Biliary System. Jubb, Kennedy & Palmer's Pathology of Domestic Animals. 2016;2:258–352. doi: 10.1016/B978-0-7020-5318-4.00008-5.

Ahmed SAAS. A Study of Liver Disease Using Computed Tomography: Sudan University of Science & Technology. 2019.

Ozougwu JC. Physiology of the liver. International Journal of Research in Pharmacy and Biosciences. 2017;4(8):13-24.

Kalra A, Yetiskul E, Wehrle CJ and Tuma F. Physiology, liver. StatPearls. 2018.

Kim IH, Kisseleva T and Brenner DA. Aging and liver disease. Curr Opin Gastroenterol. 2015;31(3):184-91. doi: 10.1097/MOG.0000000000000176.

Asrani SK, Devarbhavi H, Eaton J and Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014.

Pimpin L, Cortez-Pinto H, Negro F, Corbould E, Lazarus JV and Webber L et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69(3):718-735. doi: 10.1016/j.jhep.2018.05.011.

Degasperi E and Colombo M. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. Lancet Gastroenterol Hepatol. 2016;1(2):156-164. doi: 10.1016/S2468-1253(16)30018-8.

Osman HEA. Evaluation of Diagnostic Performance of Computed Tomography in Diagnosis of Liver Diseases: Sudan University of Science and Technology. 2017.

Mohammed AAA and Ayad CE. Volumetric and Dimensional Evaluation of the Liver in Patients with Different liver Pathologies: Computed Tomography Based study. 2019.

Kisseleva T and Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18(3):151-166. doi: 10.1038/s41575-020-00372-7.

Rajekar H. Complication of cirrhosis portal hypertension: a review. J. Liver. 2015;4(188):2167-0889. doi.org/10.4172/2167-0889.1000188.

Eguchi A and Feldstein AE. Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases. Liver Res. 2018;2(1):30-34. doi: 10.1016/j.livres.2018.01.001.

Abd El-Kader SM and El-Den Ashmawy EM. Non-alcoholic fatty liver disease: The diagnosis and management. World J Hepatol. 2015;7(6):846-58. doi: 10.4254/wjh.v7.i6.846.

Mitra S, De A and Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Transl Gastroenterol Hepatol. 2020;5:16. doi: 10.21037/tgh.2019.09.08.

Bertolotti M, Lonardo A, Mussi C, Baldelli E, Pellegrini E and Ballestri S et al. Nonalcoholic fatty liver disease and aging: epidemiology to management. World J Gastroenterol. 2014;20(39):14185-204. doi: 10.3748/wjg.v20.i39.14185.

van Aerts RMM, van de Laarschot LFM, Banales JM and Drenth JPH. Clinical management of polycystic liver disease. J Hepatol. 2018;68(4):827-837. doi: 10.1016/j.jhep.2017.11.024.

Gevers TJ and Drenth JP. Diagnosis and management of polycystic liver disease. Nat Rev Gastroenterol Hepatol. 2013;10(2):101-8. doi: 10.1038/nrgastro.2012.254.

Akhondi H and Sabih DE. Liver abscess. StatPearls. 2019.

Jha AK, Das A, Chowdhury F, Biswas MR, Prasad SK and Chattopadhyay S. Clinicopathological study and management of liver abscess in a tertiary care center. J Nat Sci Biol Med. 2015;6(1):71-5. doi: 10.4103/0976-9668.149091.

Bajenaru N, Balaban V, Săvulescu F, Campeanu I and Patrascu T. Hepatic hemangioma -review-. J Med Life. 2015;8 Spec Issue(Spec Issue):4-11.

Toro A, Mahfouz AE, Ardiri A, Malaguarnera M, Malaguarnera G and Loria F et al. What is changing in indications and treatment of hepatic hemangiomas. A review. Ann Hepatol. 2014;13(4):327-39.

Leon M, Chavez L and Surani S. Hepatic hemangioma: What internists need to know. World J Gastroenterol. 2020;26(1):11-20. doi: 10.3748/wjg.v26.i1.11.

Özdemir E, Akbulut S, Kutlutürk K and Yılmaz S. Giant hepatic hemangioma: An unusual cause of gastric compression. Turk J Gastroenterol. 2019;30(10):930-931. doi: 10.5152/tjg.2019.18778.

Rialon KL, Murillo R, Fevurly RD, Kulungowski AM, Christison-Lagay ER and Zurakowski D et al. Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas. J Pediatr Surg. 2015;50(5):837-41. doi: 10.1016/j.jpedsurg.2014.09.056.

Alarmo E-L, Huhtala H, Korhonen T, Pylkkänen L, Holli K and Kuukasjärvi T et al. Bone morphogenetic protein 4 expression in multiple normal and tumor tissues reveals its importance beyond development. Mod Pathol. 2013;26(1):10-21. doi: 10.1038/modpathol.2012.128.

Bohte AE, van Werven JR, Bipat S and Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol. 2011;21(1):87-97. doi: 10.1007/s00330-010-1905-5.

De Lédinghen V, Vergniol J, Foucher J, Merrouche W and le Bail B. Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 2012;32(6):911-8. doi: 10.1111/j.1478-3231.2012.02820.x.

Liu Z, Song Y-Q, Sheng VS, Wang L, Jiang R and Zhang X et al. Liver CT sequence segmentation based with improved U-Net and graph cut. Expert Systems with Applications. 2019;126:54-63. doi.org/10.1016/j.eswa.2019.01.055.

Mohamed TMAK. Study of Liver Diseases using Triphasic Computed Tomography Scan Protocol: Sudan University of Science and Technology. 2018.

Downloads

Published

2022-04-30

How to Cite

Akram, M. ., John, A. ., Bhatti, A. S. ., Esha, ., & Ali, A. (2022). Frequency of Acute and Chronic Liver Diseases Diagnosed on Computed Tomography: Acute and Chronic Liver Diseases on CT. Pakistan BioMedical Journal, 5(4), 162–165. https://doi.org/10.54393/pbmj.v5i4.375

Issue

Section

Original Article

Most read articles by the same author(s)

1 2 > >>